Nexium drives 7% Consumer growth at Pfizer

28 October 2015 - Deborah Wilkes

Pfizer said a 7% rise in worldwide sales by its Consumer Healthcare division in the third quarter of 2015 was primarily due to the performance of Nexium 24HR in the US.